Depression of physical activity by contraceptive pills

Oral contraceptive use: implications for cognitive and emotional functioning

This study investigated the role of oral contraception use versus nonuse as a moderator variable differentially influencing cognitive-emotional processes. Seventy-six healthy women (29 users and 47 nonusers; 18 to 48 years old), completed the State-Trait Anger Expression Inventory, the Clinical Analysis Questionnaire, the Rotter Scale of locus of control, the Daily Hassles Scale, and a Repertory Grid. A subsample (N = 33) also volunteered for a blood draw. Hormonal levels of progesterone and estrogen mostly were unrelated to cognitive and emotional measures, and contraindicated the "chemical suppression" proposition. Alternatively, when cognitive-emotional functioning was examined separately for users and nonusers, cognitive factors including the appraisal of stress, loci of control, and self-integration were implicated with specific patterns of negative affect and much more so for users than for nonusers. For the most part, oral contraceptive use versus nonuse seemed to influence the saliency rather than the nature of cognitive-emotional patterns. Discussion focused on oral contraceptive use as a moderator variable and the need for longitudinal research to clarify the evolving, biopsychosocial influence of hormonal regulatory treatment.

The menstrual cycle from a bio-behavioral approach: A comparison of oral contraceptive and non-contraceptive users

The purpose of the present study was to clarify the effects of the menstrual cycle on: (1) accuracy and simple reaction time in a problem-solving situation; (2) academic performance; (3) identify corresponding cyclic changes in a set of psychophysiological measures during rest/test conditions; and (4) to compare oral contraceptive with non-oral contraceptive users. Eight volunteer females, 4 normally cyclic and 4 oral contraceptive users, reported once weekly throughout two menstrual cycles during which changes in blood pressure, heart rate, skin temperature, finger pulse amplitude, and verbal reaction time were monitored. Differences in verbal reaction time were found between oral contraceptive users and non-users over phases of the cycle, the users being significantly slower during menstrual and premenstrual phases. It was also observed that all subjects reacted slower in the menstrual and ovulatory phases during cycle one, although no differences were found during cycle two. Skin temperature changes between groups occurred during the postovulatory phase of cycle two, the control group having shown a much greater increase than oral contraceptive users. These results indicated a suppressive influence of oral contraceptives which appeared to affect cognitive rather than motor responses, and that these effects were residual when no pills were taken menstrually and premenstrually. Also indicated was the finding that although a 28-day cycle of menstrual events exists, periodicity of these events may be reflected in a much larger cycle non-currently defined.

Oral contraceptives and psychiatric disturbance: evidence from research

There is a commonly held conviction among physicians and the lay public that oral contraceptive agents are associated with a high incidence of adverse psychological effects, particularly depressive symptoms. This belief is enhanced by a body of literature which includes case reports, studies of small samples, and overall side effect incidence rates (1–22). Careful, adequately controlled, objective studies of emotional reactions are, however, lacking, and this can be ascribed to the serious problems inherent in the design of such studies. For example, adequate control groups are difficult to establish, and contraceptives cannot easily be randomly assigned. Studies using a placebo must also introduce other contraceptives; nonrandom processes operate in the selection of women for study. Suggestibility secondary to use of medication requires placebo double-blind studies in order to differentiate the psychological from the pharmacological effects.